Linking mucus plugs and chronic bronchitis to bronchodilator responsiveness in young adult smokers: BEACON cohort
<bold>BACKGROUND:</bold> In COPD and asthma, mucus plugging is common but poorly corresponds to symptoms. To investigate if plugging and chronic bronchitis reflect different mucus dysfunction phenotypes, we assessed how their presence/absence related to airway hyper-responsiveness in young adult smokers. <bold>METHODS:</bold> The British Early COPD Network (BEACON) enrolled 30–45-year-old smokers with ≥10 pack year smoking history and FEV1%predicted≥80% without diagnosed/treated asthma. We compared FEV1 bronchodilator reversibility and blood eosinophil count according to the presence/absence of both chronic bronchitis (clinical, CAT, MRC and SGRQ definitions) and mucus plugs (full inspiratory CT thorax scan). <bold>RESULTS:</bold> Among 404 BEACON subjects (60% male; 82% Caucasian; median age 39 (IQR:35-42) years; median pack years 16 (IQR:12-21); FEV1% 100% (IQR:93-109)), 192(48%) reported chronic bronchitis (any definition), 38(9%) had mucus plugs. Those with plugs had greater FEV1 reversibility: 185(IQR:85-253) vs 130(IQR:50-220)mL(P=0.04) and more frequently had bronchodilator responsiveness than those without (P=0.03). We found no difference by chronic bronchitis presence and no differences in eosinophil counts (Fig.1). <bold>CONCLUSION:</bold> FEV1 reversibility was over-represented among those with mucus plugs, but not among those with chronic bronchitis, potentially indicating different pathological processes present among young adult smokers. <fig><object-id>erj;66/suppl_69/OA6435/F1</object-id><object-id>F1</object-id><object-id>F1</object-id><graphic></graphic></fig>
Authors
- Paul Jones (ORCID: https://orcid.org/0000-0001-6087-9182)
- Peter M.A. Calverley (ORCID: https://orcid.org/0000-0003-4676-9993)
- Robert Andrew Stockley (ORCID: https://orcid.org/0000-0003-3726-1207)
- Mirco Govoni (ORCID: https://orcid.org/0000-0002-7834-7237)
- Eric A. Hoffman (ORCID: https://orcid.org/0000-0001-8456-9437)
- Kristoffer Ostridge (ORCID: https://orcid.org/0000-0001-8910-3900)
- Luana Alves-Moreira
- Hana Müllerová (ORCID: https://orcid.org/0000-0002-0949-0101)
- Lorcan McGarvey (ORCID: https://orcid.org/0000-0002-2860-0302)
- Julie Yates (ORCID: https://orcid.org/0000-0001-5711-4349)
- Elizabeth Sapey (ORCID: https://orcid.org/0000-0003-3454-5482)
- Andrew I. Ritchie
- D.G. Downey (ORCID: https://orcid.org/0000-0002-6471-549X)
- Augusta S. Beech (ORCID: https://orcid.org/0000-0002-2690-5364)
- Sam Bartlett‐Pestell (ORCID: https://orcid.org/0000-0002-8570-9355)
- James P. Allinson (ORCID: https://orcid.org/0000-0002-3117-7533)
- Charlotte E. Bolton (ORCID: https://orcid.org/0000-0002-9578-2249)
- Tom Wilkinson (ORCID: https://orcid.org/0000-0003-1771-3851)
- Lydia Finney (ORCID: https://orcid.org/0000-0003-2226-9513)
- Apolline Marion
- Federico Baraldi (ORCID: https://orcid.org/0009-0007-5649-8409)
- Jørgen Vestbo (ORCID: https://orcid.org/0000-0001-6355-6362)
- Gourab Choudhury (ORCID: https://orcid.org/0000-0002-2595-8253)
- Aaron Braddy-Green (ORCID: https://orcid.org/0000-0003-0295-7634)
- Mairi Macleod (ORCID: https://orcid.org/0000-0002-0910-4485)
- Chris Compton
- Dave Singh (ORCID: https://orcid.org/0000-0001-8918-7075)
- Jadwiga A. Wedzicha
- Jordina Mah
Institutions
- AstraZeneca (United Kingdom) (GB)
- Queen's University Belfast (GB)
- University of Iowa (US)
- University of Liverpool (GB)
- University of Ferrara (IT)
- Manchester Academic Health Science Centre (GB)
- University College Birmingham (GB)
- Brentwood Hospital (US)
- Lung Institute (US)
- Chiesi Foundation (IT)
- Nottingham Biomedical Research Centre (GB)
- Centre for Inflammation Research (GB)
- The Queen's Medical Research Institute (GB)
- University of Southampton (GB)
- University of Birmingham (GB)
Publication Details
- Published
- 2025-09-27
- DOI
- https://doi.org/10.1183/13993003.congress-2025.oa6435
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00